Rifaximin (Xifaxan) - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • July 26, 2024
  • July 22, 2022
  • May 2018
  • June 2017
  • June 2015
  • Oct. 2013
  • Dec. 2011
  • April 2010
  • Dec. 2006.
  • Sept. 2006 (initially developed)